Endurance Wealth Management’s Organon & Co OGN Stock Holding History

Endurance Wealth Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$9K	Sell	424 -12	-3%	-$261	﹤0.01%	503
2023 Q1	$10K	Hold	436	–	–	﹤0.01%	504
2022 Q4	$12K	Sell	436 -12	-3%	-$307	﹤0.01%	466
2022 Q3	$10K	Sell	448 -18	-4%	-$543	﹤0.01%	474
2022 Q2	$16K	Sell	466 -44	-9%	-$1.54K	﹤0.01%	438
2022 Q1	$18K	Sell	510 -45	-8%	-$1.54K	﹤0.01%	458
2021 Q4	$17K	Sell	555 -1,032	-65%	-$33.6K	﹤0.01%	464
2021 Q3	$52K	Buy	+1,587	New	+$50.8K	0.01%	353

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Endurance Wealth Management's OGN Position: Q2 2023 in Review

Endurance Wealth Management reduced its Organon & Co (OGN) stake by 2.8% in Q2 2023, selling an estimated $261 and leaving 424 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #503.

Endurance Wealth Management first reported a position in OGN in Q3 2021 and has held it in 8 quarters since. The position peaked at $52K in Q3 2021. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

Endurance Wealth Management held 424 shares of Organon & Co worth $9K as of Q2 2023.
Endurance Wealth Management sold 12 Organon & Co shares in Q2 2023, an estimated $261.
Organon & Co made up ﹤0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #503 holding.
Endurance Wealth Management first reported a position in Organon & Co in Q3 2021 and has held it in 8 quarters since.
Endurance Wealth Management's Organon & Co position peaked at $52K in Q3 2021.
726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.